Home › Compare › MOTUY vs ABBV
MOTUY yields 14.93% · ABBV yields 3.06%● Live data
📍 MOTUY pulled ahead of the other in Year 1
Combined, MOTUY + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MOTUY + ABBV for your $10,000?
Motus Holdings Limited operates in the automotive sector in South Africa and internationally. It operates through four segments: Import and Distribution, Retail and Rental, Mobility Solutions, and Aftermarket Parts. The Import and Distribution segment imports and distributes passenger and light commercial vehicles (LCV), as well as its parts to a network of dealerships, car rental companies, fleets, and government institutions. The Retail and Rental segment sells new and pre-owned passenger and commercial vehicles in various segments, as well as rents passenger and LCVs. It has 23 original equipment manufacturers (OEMs) through 345 dealerships, including 104 pre-owned, 206 passenger vehicle, and 36 commercial vehicle dealerships in South Africa; and 19 OEMs through 115 dealerships comprising 82 commercial and 33 passenger dealerships in the United Kingdom, as well as 20 OEMs through 36 passenger dealerships in Australia. This segment also rents cars under the Europcar and Tempest brands; sells parts and accessories; and engages in servicing and maintenance of vehicles. The Mobility Solutions segment develops, manages, sells, and administers service, maintenance, and warranty plans; and provides value added products and services, business process outsourcing, and fleet management services. This segment also develops and distributes various vehicle-related financial products and services through importers, distributors, dealers, finance houses, call centers, and digital channels. The Aftermarket Parts segment distributes, wholesales, and retails parts, accessories, and aftermarket parts for out-of-warranty vehicles through retail and franchised stores, and specialized workshops. This segment operates 564 retail stores, including 102 owned stores in South Africa, Taiwan, China, and the United Kingdom. It is also involved in the property investment activities. The company was founded in 1948 and is based in Bedfordview, South Africa.
Full MOTUY Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.